找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Drug-Induced Liver Toxicity; Minjun Chen,Yvonne Will Book 2018 Springer Science+Business Media, LLC, part of Springer Nature 2018 Acute li

[復(fù)制鏈接]
查看: 12416|回復(fù): 57
樓主
發(fā)表于 2025-3-21 19:04:40 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Drug-Induced Liver Toxicity
編輯Minjun Chen,Yvonne Will
視頻videohttp://file.papertrans.cn/284/283168/283168.mp4
概述Includes cutting-edge techniques for the study of DILI.Contains key implementation advice from the experts.Features detail essential for labs, from basic research through to clinical action
叢書名稱Methods in Pharmacology and Toxicology
圖書封面Titlebook: Drug-Induced Liver Toxicity;  Minjun Chen,Yvonne Will Book 2018 Springer Science+Business Media, LLC, part of Springer Nature 2018 Acute li
描述This book provides a comprehensive view of the methodologies used for the study of liver toxicity encountered throughout the whole life cycle of a drug, from drug discovery, to clinical trial, post-marketing, and even clinical practice. Organized into six sections, the first section introduces the mechanisms contributing to drug-induced liver toxicity.? The second and third section explore in silico and in vitro approaches used to help mitigate hepatotoxicity liability at the early stages of drug development. The fourth section describes methodologies applied in regulatory processes, including preclinical studies, clinical trials, and post-marketing surveillance. The fifth section discusses clinical hepatotoxicity. Emerging technologies are examined in the final section. As a volume in the Methods in Pharmacology and Toxicology series, chapters include the kind of expert advice that will lead to optimal results.?.Authoritative and practical, .Drug-InducedLiver Toxicity. serves all those who aim to improve assessment and understanding of hepatotoxic potentials of new medications and marketed drugs..Chapter 30 is open access under a CC BY 4.0 license via link.springer.com.?.
出版日期Book 2018
關(guān)鍵詞Acute liver failure; Drug development; Regulatory processes; Preclinical and clinical studies; Hepatotox
版次1
doihttps://doi.org/10.1007/978-1-4939-7677-5
isbn_softcover978-1-4939-9256-0
isbn_ebook978-1-4939-7677-5Series ISSN 1557-2153 Series E-ISSN 1940-6053
issn_series 1557-2153
copyrightSpringer Science+Business Media, LLC, part of Springer Nature 2018
The information of publication is updating

書目名稱Drug-Induced Liver Toxicity影響因子(影響力)




書目名稱Drug-Induced Liver Toxicity影響因子(影響力)學(xué)科排名




書目名稱Drug-Induced Liver Toxicity網(wǎng)絡(luò)公開度




書目名稱Drug-Induced Liver Toxicity網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Drug-Induced Liver Toxicity被引頻次




書目名稱Drug-Induced Liver Toxicity被引頻次學(xué)科排名




書目名稱Drug-Induced Liver Toxicity年度引用




書目名稱Drug-Induced Liver Toxicity年度引用學(xué)科排名




書目名稱Drug-Induced Liver Toxicity讀者反饋




書目名稱Drug-Induced Liver Toxicity讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 23:13:36 | 只看該作者
Detection, Elimination, Mitigation, and Prediction of Drug-Induced Liver Injury in Drug Discovery major hurdle and is recognized to be a major cause of drug attrition and market withdrawal. DILI impacts many different sectors of society including patients, public health systems, health insurers and the pharmaceutical industry. Animal models are very efficient at detecting direct, dose-dependent
板凳
發(fā)表于 2025-3-22 01:07:04 | 只看該作者
地板
發(fā)表于 2025-3-22 07:09:02 | 只看該作者
Physicochemical Properties and Structural Alertsm the market. Significant efforts are being made to utilize existing knowledge of chemical and biological mechanisms that have been linked with causing DILI. These mechanisms are often varied and can include overt chemical reactivity or bioactivation to reactive metabolites; unintended interactions
5#
發(fā)表于 2025-3-22 09:11:23 | 只看該作者
6#
發(fā)表于 2025-3-22 14:03:00 | 只看該作者
7#
發(fā)表于 2025-3-22 19:23:11 | 只看該作者
Prediction of Human Liver Toxicity Using In Vitro Assays: Limitations and Opportunitiess. Simple single cell-type in vitro cytotoxicity assays may fail to predict complex in vivo interconnected mechanism-based toxicities. Additionally, the lack of standardization of in vitro assays complicates data interpretation and makes assay comparison difficult. The selection of a given assay may
8#
發(fā)表于 2025-3-22 21:39:28 | 只看該作者
Use of Liver-Derived Cell Lines for the Study of Drug-Induced Liver Injurycytes. Multiple hepatocyte derived cellular carcinoma cell lines, such as HepG2, Huh7, and HepaRG cells, have been established over the years, and they display distinct characteristics regarding the expression and activity levels of drug-metabolizing enzymes and other hepatocyte-specific factors. Th
9#
發(fā)表于 2025-3-23 01:36:51 | 只看該作者
Evaluation of Drug-Induced Liver Injuries (DILI) with Human Hepatocytes: Scientific Rationale and Ex. Here the Human Cell Paradigm, namely, that human-specific drug properties can be obtained with in vitro human-based experimental systems is proposed. The success of the Human Cell Paradigm depends on the physiological relevance of the in vitro system, namely, the retention of human-specific and or
10#
發(fā)表于 2025-3-23 07:08:41 | 只看該作者
Status and Use of Induced Pluripotent Stem Cells (iPSCs) in Toxicity Testingon reasons given for drug attrition or withdrawal; this occurs for a multitude of reasons among which is certainly the lack of adequate models able to recapitulate hepatotoxicity in vitro. The loss of compounds in late-stage testing or after marketing is a major financial burden for the pharmaceutic
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-11 18:33
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
青浦区| 天峻县| 镇康县| 彭水| 青冈县| 新巴尔虎左旗| 北宁市| 阜康市| 承德县| 新民市| 高淳县| 中方县| 漾濞| 延川县| 米泉市| 武胜县| 门头沟区| 滁州市| 浪卡子县| 溧水县| 忻州市| 衡阳县| 中阳县| 集安市| 绥棱县| 德惠市| 嘉峪关市| 咸阳市| 昆明市| 崇左市| 荃湾区| 东港市| 防城港市| 盐山县| 大渡口区| 彝良县| 富裕县| 黄浦区| 涟源市| 定南县| 武穴市|